This tool can be used to report the following types of issues for covered outpatient drugs, to the Health Resources and Services Administration (HRSA): Unavailable 340B ceiling price and/or incorrect 340B ceiling price (overcharge).
↧
Trending Articles
More Pages to Explore .....